The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer

Expert Review of Anticancer Therapy
Christophe A DoomsJohan F Vansteenkiste

Abstract

Differences in survival outcomes with various treatments for advanced non-small cell lung cancer are very modest. Despite this, end points looking at the patients' subjective benefit, such as symptom control, quality of life or clinical benefit, have only been sparsely implemented into clinical trials as primary points of interest. This review focuses on available evidence regarding these patients' subjective end points in recent clinical trials. Compared with best supportive care, chemotherapy offers symptom control, not only in patients with objective response to chemotherapy, but also in a proportion of patients with disease stabilization. However, interpretation of quality-of-life objectives is more difficult, owing to several methodological problems, but improvement in various domains of quality of life is also reported. Different treatment options, such as older platinum-based schedules, modern platinum-based doublets, single-agent treatment with a new drug or nonplatinum-based doublets, are comprehensively reviewed. Future randomized studies should take up the challenge of looking at the patients' benefit as a primary end point.

References

May 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H SchipperM Levitt
Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Jun 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·D F CellaP Bonomi
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R JettJ W Kugler
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J HollenL M Potanovich
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R GrilliJ A Julian
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SloanN L Vaught
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M HelsingU Hero
May 21, 1999·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·P J HollenC Cox
Jul 14, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S ThongprasertJ Clinch
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F CardenalR Rosell
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H CullenR L Souhami
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L CrinòM Tonato
Nov 24, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·W W ten Bokkel HuininkC Manegold
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A B SandlerL H Einhorn
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F A ShepherdJ Berille
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FrasciM De Lena
Oct 3, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U GatzemeierG Gallant
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I E SmithS Ashley
Nov 8, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J F VansteenkisteUNKNOWN Leuven Lung Cancer Group
Feb 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L J Billingham, M H Cullen
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A SocinskiMerrill S Kies
May 23, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C M MoinpourD R Gandara
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G V ScagliottiUNKNOWN Italian Lung Cancer Project
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Egbert F SmitUNKNOWN European Organization for Research and Treatment of Cancer Lung Cancer Group
Dec 31, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Adriano PaccagnellaUNKNOWN GSTVP (Gruppo di Studio Tumori Polmonari del Veneto)

❮ Previous
Next ❯

Citations

Feb 8, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mellar P Davis, Jordanka Kirkova
Mar 26, 2009·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Sui-Zan ZhouYan Wang
Dec 20, 2012·Expert Review of Anticancer Therapy·Navneet SinghDigambar Behera
Aug 19, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Yanni Hao
Jun 5, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lies PeetersJohan Vansteenkiste
Sep 8, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Tuğba Karakoç, Sabire Yurtsever
Aug 30, 2012·Cancer·Charles S CleelandUNKNOWN CPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force
Oct 24, 2007·Journal of the National Cancer Institute. Monographs·Edwin P RockLaurie B Burke
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cesare GridelliSteven E Schild
Oct 17, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Grace E DeanSuzanne S Dickerson
Jan 4, 2019·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Iknur Aydin AvciAyse Buberci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
N ThatcherH Anderson
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Richard J Gralla, Frank Griesinger
Hematology/oncology Clinics of North America
Michelle Boyar, Harry Raftopoulos
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Chandra P BelaniTAX 326 study group
© 2022 Meta ULC. All rights reserved